News

Dr. Susana Morales, director of the Weill Cornell Medicine Diversity Center of Excellence, has been named the 2022 Physician of the Year by the National Hispanic Medical Association (NHMA) for her continued leadership to improve Hispanic health and efforts to advance health equity.

With a generous gift of $10 million from Board of Fellows member Alan Hartman and his wife, Kim, Weill Cornell Medicine will establish a multidisciplinary research institute to advance organ regeneration and repair.

Using cutting-edge techniques, Weill Cornell Medicine and Memorial Sloan Kettering investigators have visualized the structure of a receptor targeted by an anti-cancer immunotherapy.

All of the 116 students in Weill Cornell Medical College’s Class of 2022 who entered the match this year secured postgraduate residency positions, 87 percent of which at institutions ranked in the top 50 by U.S. News and World Report.

Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target...

Individual Candida albicans yeast strains in the human gut are as different from each other as the humans that carry them, and some C. albicans strains may damage the gut of patients with inflammatory bowel disease (IBD), according to a new study from researchers at Weill Cornell Medicine.

Most patients with severe COVID who are put on ventilators regain consciousness after removal of respiratory support, but recovery may take weeks after the period of mechanical ventilation has ended, according to a new study by investigators at Weill Cornell Medicine, Columbia University Vagelos College of Physicians and Surgeons, Harvard Medical School, .NewYork-Presbyterian and Massachusetts General Hospital.

Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium. Both grants will fund work applying new technologies to develop more detailed knowledge of tumor biology, with one team focusing on Hodgkin lymphoma and the other on the purity of tumor samples on pathology slides.

High levels of anti-Mullerian hormone (AMH) have traditionally been thought of as merely a passive byproduct of polycystic ovary syndrome (PCOS), but a new preclinical study by Weill Cornell Medicine researchers suggests that the hormone plays an active role in the disorder and may contribute to problems with ovulation and fertility.

Dr. Camilia Martin, an esteemed physician-scientist who combines clinical care and innovative research on neonatal nutrition to improve outcomes for premature and newborn babies, has been named chief of the Division of Newborn Medicine at Weill Cornell Medicine and NewYork-Presbyterian Komansky Children’s Hospital, effective May 1.

Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.

Three Weill Cornell Medicine faculty members have received Young Physician-Scientist Awards from the American Society for Clinical Investigation. The 2022 award recipients are Drs. Bishoy M. Faltas, Gunisha Kaur and Hasina Outtz Reed.

Anesthesiology prices jump significantly after medical facilities contract with corporate physician management companies – especially those backed by private equity firms – and threaten to hike patient costs, according to new research by Weill Cornell Medicine and Columbia University Mailman School of Public Health investigators. 

Are you a COVID-19 ‘long-hauler’? Are you worried that your lingering exhaustion or shortness of breath indicate damage to your heart?

Awards, honors, prizes and achievements for the month of February.

A finding from Weill Cornell Medicine researchers sheds new light on the transmission of malaria, one of the biggest global public health challenges, which kills a young child every two minutes – more than any other infectious disease.

A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine physician-scientists who performed the transplant and managed her care.

Two Weill Cornell Medicine physician-scientists, Dr. Randy Longman and Dr. Robert Schwartz, have been elected as members of the American Society for Clinical Investigation.

Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.

A three-year contract from Wellcome Leap will allow a team of investigators from Weill Cornell Medicine, Stanford Medicine and UC San Diego School of Medicine to study new ways to combat depression and create models that can predict which treatment is likely to work for individual patients.